Pharmaceutical Preparations · DE · CIK 1374690
Developing treatments for rare diseases using cell penetrating peptide technology
Comparable business profile · signals at a glance
In the 90 days to Feb 27, 2026: 4 insiders bought $25.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | Deerfield Mgmt Hif, L.P.Director,TenPercentOwner,Other | Buy | 2,000,000 | $5.00 | $10.0M |
| Feb 27, 2026 | Deerfield Mgmt Hif, L.P.Director,TenPercentOwner,Other | Buy | 1,084,012 | $5.00 | $5.4M |
| Feb 27, 2026 | Deerfield Mgmt Hif, L.P.Director,TenPercentOwner,Other | Buy | 1,084,010 | $5.00 | $5.4M |
| Feb 27, 2026 | Deerfield Mgmt Hif, L.P.Director,TenPercentOwner,Other | Buy | 831,978 | $5.00 | $4.2M |
| Feb 27, 2026 | Hamilton Thomas EdwardDirector | Buy | 100,000 | $5.00 | $500K |
| Feb 27, 2026 | Thomas Frank EDirector | Buy | 5,000 | $5.00 | $25K |
| Feb 27, 2026 | Sherman Jeffrey WDirector | Buy | 5,000 | $5.00 | $25K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.